Norges Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112M Buy
+2,043,879
New +$112M 0.01% 660
2025
Q1
Sell
-3,569,831
Closed -$235M 241
2024
Q4
$235M Buy
+3,569,831
New +$235M 0.03% 428
2024
Q3
Sell
-3,619,503
Closed -$298M 244
2024
Q2
$298M Buy
3,619,503
+140,991
+4% +$11.6M 0.04% 349
2024
Q1
$304M Buy
3,478,512
+117,202
+3% +$10.2M 0.05% 336
2023
Q4
$324M Buy
3,361,310
+318,010
+10% +$30.7M 0.06% 299
2023
Q3
$269M Buy
3,043,300
+6,801
+0.2% +$602K 0.05% 311
2023
Q2
$263M Buy
3,036,499
+152,016
+5% +$13.2M 0.05% 324
2023
Q1
$280M Buy
2,884,483
+130,466
+5% +$12.7M 0.06% 292
2022
Q4
$285M Buy
2,754,017
+157,654
+6% +$16.3M 0.07% 275
2022
Q3
$220M Buy
2,596,363
+32,727
+1% +$2.77M 0.06% 309
2022
Q2
$212M Buy
2,563,636
+5,338
+0.2% +$442K 0.05% 316
2022
Q1
$197M Buy
2,558,298
+208,758
+9% +$16.1M 0.04% 388
2021
Q4
$208M Buy
2,349,540
+223,693
+11% +$19.8M 0.04% 396
2021
Q3
$164M Sell
2,125,847
-42,198
-2% -$3.26M 0.04% 460
2021
Q2
$181M Sell
2,168,045
-26,274
-1% -$2.19M 0.04% 443
2021
Q1
$166M Buy
2,194,319
+744,823
+51% +$56.2M 0.04% 446
2020
Q4
$127M Buy
1,449,496
+32,054
+2% +$2.81M 0.03% 513
2020
Q3
$108M Sell
1,417,442
-60,415
-4% -$4.6M 0.03% 512
2020
Q2
$182M Sell
1,477,857
-75,441
-5% -$9.3M 0.05% 322
2020
Q1
$131M Sell
1,553,298
-199,543
-11% -$16.9M 0.05% 352
2019
Q4
$148M Buy
1,752,841
+245,138
+16% +$20.7M 0.04% 402
2019
Q3
$102M Sell
1,507,703
-229,622
-13% -$15.5M 0.03% 505
2019
Q2
$149M Buy
1,737,325
+256,507
+17% +$22M 0.05% 377
2019
Q1
$132M Buy
1,480,818
+293,094
+25% +$26M 0.04% 401
2018
Q4
$101M Buy
1,187,724
+117,982
+11% +$10M 0.04% 437
2018
Q3
$104M Buy
1,069,742
+109,408
+11% +$10.6M 0.03% 485
2018
Q2
$90.5M Buy
960,334
+44,480
+5% +$4.19M 0.03% 523
2018
Q1
$74.2M Buy
915,854
+37,798
+4% +$3.06M 0.03% 594
2017
Q4
$78.3M Buy
878,056
+136,767
+18% +$12.2M 0.03% 570
2017
Q3
$69M Hold
741,289
0.03% 606
2017
Q2
$67.3M Sell
741,289
-195,124
-21% -$17.7M 0.03% 596
2017
Q1
$82.2M Sell
936,413
-77,013
-8% -$6.76M 0.03% 489
2016
Q4
$84M Buy
1,013,426
+26,046
+3% +$2.16M 0.04% 476
2016
Q3
$87.3M Buy
987,380
+36,542
+4% +$3.23M 0.04% 438
2016
Q2
$74M Sell
950,838
-159,423
-14% -$12.4M 0.04% 486
2016
Q1
$91.6M Sell
1,110,261
-57,295
-5% -$4.73M 0.05% 389
2015
Q4
$122M Sell
1,167,556
-9,470
-0.8% -$992K 0.06% 291
2015
Q3
$124M Buy
1,177,026
+174,011
+17% +$18.3M 0.07% 297
2015
Q2
$137M Buy
1,003,015
+40,944
+4% +$5.6M 0.07% 281
2015
Q1
$120M Sell
962,071
-82,532
-8% -$10.3M 0.06% 320
2014
Q4
$94.4M Sell
1,044,603
-72,230
-6% -$6.53M 0.05% 366
2014
Q3
$80.6M Sell
1,116,833
-1,116,833
-50% -$80.6M 0.04% 409
2014
Q2
$139M Buy
2,233,666
+1,116,833
+100% +$69.5M 0.04% 468
2014
Q1
$76.2M Sell
1,116,833
-62,275
-5% -$4.25M 0.04% 403
2013
Q4
$82.9M Sell
1,179,108
-367,869
-24% -$25.9M 0.05% 362
2013
Q3
$112M Buy
1,546,977
+949,969
+159% +$68.6M 0.07% 296
2013
Q2
$33.3M Buy
+597,008
New +$33.3M 0.02% 722